RESEARCH PROGRAMS:
MMRF CoMMpass Study
In The News
Press Releases
Multiple Myeloma Research Consortium (MMRC) and Synta Pharmaceuticals Announce First Patient in Clinical Trial in Multiple Myeloma - April 10, 2012
The Multiple Myeloma Research Foundation (MMRF) Presents Study Design for Landmark Trial Focused on Genomic Analysis at the AACR Annual Meeting - April 3, 2012
The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study - December 19, 2011
Multiple Myeloma Research Foundation (MMRF) and Onyx Pharmaceuticals Announce Multi-Year Collaboration to Accelerate Personalized Medicine Approaches for Multiple Myeloma - December 14, 2011
Multiple Myeloma Research Foundation (MMRF) Announces Millennium as First Industry Partner in Innovative Collaboration to Advance Personalized Medicine for Multiple Myeloma - September 29, 2011
Multiple Myeloma Research Foundation (MMRF) Announces First Patient Enrolled in Landmark 1000-Patient Study, with Four World-Class Cancer Centers as First Clinical Sites - September 20, 2011
How do I find out more?
Those who are interested in learning more about the MMRF CoMMpass℠ study and whether they qualify, should call 203-652-0213 or contact Beverly Harrison at harrisonb@themmrf.org.
